ID |
IPI |
Description |
Subcellular localization |
Protein abundance and peptides identification |
GroSize |
ProGroup |
PM |
Cyto |
Mito |
rER |
sER |
Nucl |
1081 |
IPI00021274.2 |
Ephrin type-A receptor 8 precursor |
PM(G2,GO) |
- |
- |
- |
1.96E-02 (DLAARNVLVDSNLVCK;NLAAFSEAVTGADSSSLVEVR;LNTEVRSVGPLSK) |
- |
- |
1 |
IPI00021274.2
|
1082 |
IPI00021290.5 |
ATP-citrate synthase |
Cyto(SP,GO,HPA); Nucl(GO,HPA); PM(HPA) |
- |
2.43E-01 (AFDSGIIPMEFVNK;DGVYVLDLAAK;DLVSSLTSGLLTIGDR;FICTTSAIQNR;GVTIIGPATVGGIKPGCFK;IGNTGGMLDNILASK;ILIIGGSIANFTNVAATFK;LGLVGVNLTLDGVK;MIVVLGEIGGTEEYK;VDATADYICK;WGDIEFPPPFGR;AVQGMLDFDYVCSR;DYQGPLKE |
- |
- |
- |
- |
1 |
IPI00021290.5
|
1083 |
IPI00021292.3 |
Isoform 1 of Troponin T, cardiac muscle |
Cyto(G2,GO) |
- |
- |
3.44E-02 (ALSNMMHFGGYIQK;VLAIDHLNEDQLREK) |
- |
- |
- |
10 |
IPI00021292.3, IPI00145107.3, IPI00218306.1, IPI00218307.1, IPI00218309.1, IPI00218312.2, IPI00218313.4, IPI00471956.3, IPI00478301.3, IPI00654551.3
|
1084 |
IPI00021298.1 |
Keratin, type I cytoskeletal 20 |
Cyto(SP,GO) |
- |
- |
- |
- |
1.38E-02 (LEQEIATYR;TRLEQEIATYR;LGTTPSVYGGAGGRGIR) |
- |
1 |
IPI00021298.1
|
1085 |
IPI00021301.1 |
Aspartoacylase |
Cyto(G2,SP,GO,HPA) |
- |
4.49E-02 (YPVGIEVGPQPQGVLR;AQEINHLFGPK;NNFLIQMFHYIK) |
- |
- |
- |
- |
2 |
IPI00021301.1, IPI00790886.1
|
1086 |
IPI00021304.1 |
Keratin, type II cytoskeletal 2 epidermal |
ER(G1); Cyto(GO,HPA) |
1.07E+00 (NLDLDSIIAEVK;FASFIDK;FLEQQNQVLQTK;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;GFSSGSAVVSGGSR;LNDLEEALQQAK;NVQDAIADAEQR;SKEEAEALYHSK;TAAENDFVTLK;VDLLNQEIEFLK;YEELQVTVGR;IEISELNR;PINLEPIFQGYI |
9.76E-01 (IEISELNR;FLEQQNQVLQTK;LALDVEIATYR;NLDLDSIIAEVK;FASFIDK;LNDLEEALQQAK;NVQDAIADAEQR;SISISVAGGGGGFGAAGGFGGR;VDLLNQEIEFLK;YEELQVTVGR;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;GFSSGSAVVSGGSR;NK |
4.07E-01 (IEISELNR;FLEQQNQVLQTK;LNDLEEALQQAK;NVQDAIADAEQR;VDLLNQEIEFLK;YEELQVTVGR;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;NLDLDSIIAEVK;TAAENDFVTLK) |
4.86E+00 (NLDLDSIIAEVK;LALDVEIATYR;FASFIDK;FLEQQNQVLQTK;IEISELNR;DYQELMNVK;TSQNSELNNMQDLVEDYKK;DVDNAYMIK;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;GGGFGGGSGFGGGSGFGGGSGFSGGGFGGGGFGGGR;LNDLEEALQQAK; |
4.50E+00 (NLDLDSIIAEVK;DYQELMNVK;LALDVEIATYR;FASFIDK;FLEQQNQVLQTK;IEISELNR;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;LNDLEEALQQAK;NVQDAIADAEQR;PINLEPIFQGYIDSLK;PINLEPIFQGYIDSLKR;SISISVAGGGGGFGAAGGF |
1.64E+00 (FASFIDK;NLDLDSIIAEVK;LALDVEIATYR;NLDLDSIIAEVKAQYEEIAQR;IEISELNR;FLEQQNQVLQTK;LNDLEEALQQAK;NVQDAIADAEQR;VDLLNQEIEFLK;YEELQVTVGR;FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK;NKLNDLEEALQQAK;SKE |
1 |
IPI00021304.1
|
1087 |
IPI00021320.2 |
Bin3, bicoid-interacting 3, homolog |
Nucl(G1) |
- |
- |
- |
- |
- |
3.87E-02 (EPFLVPAPPPPLK;NSCNVGGGGGGFKHPAFK) |
1 |
IPI00021320.2
|
1088 |
IPI00021327.3 |
Isoform 1 of Growth factor receptor-bound protein 2 |
Cyto(G1,GO) |
- |
1.25E-01 (FNSLNELVDYHR;ESESAPGDFSLSVK;ATADDELSFK) |
- |
- |
4.74E-02 (FNSLNELVDYHR;YDFKATADDELSFK) |
- |
1 |
IPI00021327.3
|
1089 |
IPI00021347.1 |
Ubiquitin-conjugating enzyme E2 L3 |
Cyto(G1,SP,GO); Nucl(SP,GO) |
- |
7.16E-01 (TDQVIQSLIALVNDPQPEHPLR;IEINFPAEYPFKPPK;TDQVIQSLIALVNDPQPEHPLRADLAEEYSK) |
- |
- |
- |
- |
1 |
IPI00021347.1
|
1090 |
IPI00021369.1 |
Alpha crystallin B chain |
Cyto(G1,SP,GO); Nucl(SP,GO) |
- |
3.82E-01 (VLGDVIEVHGK;YRIPADVDPLTITSSLSSDGVLTVNGPR;IPADVDPLTITSSLSSDGVLTVNGPR;LFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLR;RPFFPFHSPSR) |
- |
- |
- |
- |
1 |
IPI00021369.1
|
1091 |
IPI00021370.1 |
huntingtin interacting protein 2 |
Cyto(G1) |
- |
7.49E-01 (IPETYPFNPPK;IWHPNISSVTGAICLDILK;VDLVDENFTELR;LWAHVYAGAPVSSPEYTK;NAVIVALSSK;TVLLSLQALLAAAEPDDPQDAVVANQYK;VDLVDENFTELRGEIAGPPDTPYEGGR;GEIAGPPDTPYEGGR) |
- |
- |
- |
- |
1 |
IPI00021370.1
|
1092 |
IPI00021396.1 |
Vascular endothelial growth factor receptor 2 precursor |
Cyto(G1); PM(GO) |
- |
1.13E-02 (DILTIK;YLGYPPPEIKWYK;GAFGQVIEADAFGIDK;LDSITSSQSSASSGFVEEK) |
4.92E-03 (DILTIK;NGIPLESNHTIKAGHVLTIMEVSER) |
- |
- |
1.33E-02 (LPYDASKWEFPRDR;GAFGQVIEADAFGIDK) |
1 |
IPI00021396.1
|
1093 |
IPI00021405.3 |
Isoform A of Lamin-A/C |
Nucl(SP,GO,HPA); Cyto(GO,HPA) |
1.12E+00 (AAYEAELGDAR;EAALSTALSEK;IDSLSAQLSQLQK;ITESEEVVSR;LADALQELR;LKDLEALLNSK;MQQQLDEYQELLDIK;NSNLVGAAHEELQQSR;TLEGELHDLR;LRDLEDSLAR;ARLQLELSKVR;LQEKEDLQELNDR) |
- |
2.26E-01 (AAYEAELGDAR;EAALSTALSEK;LKDLEALLNSK;NSNLVGAAHEELQQSR;LAVYIDR;LQEKEDLQELNDR;LADALQELR;IDSLSAQLSQLQK;LRDLEDSLAR;SVGGSGGGSFGDNLVTR) |
- |
- |
2.99E+01 (AAYEAELGDAR;DLEALLNSK;EAALSTALSEK;LALDMEIHAYR;LRDLEDSLAR;NIYSEELR;RTLEGELHDLR;DLEDSLAR;IDSLSAQLSQLQK;IRIDSLSAQLSQLQK;ITESEEVVSR;LADALQELR;LAVYIDR;LKDLEALLNSK;LQEKEDLQELNDR;LQTMKEELDFQK;MQQQL |
1 |
IPI00021405.3
|
1094 |
IPI00021417.3 |
U4/U6.U5 tri-snRNP-associated protein 1 |
Nucl(SP,GO); Cyto(GO) |
- |
- |
- |
- |
- |
8.25E-01 (DKGVLQEEEDVLVNVNLVDKER;EAAGTTAAAGTGGATEQPPR;TSSGDASSLSIEETNK;YDEELEGERPHSFR;ADDLLPLGDQTQDGDFGSR;DLQGLTVEHAIDSFR;GLAAALLLCQNK;LQAQSLSTVGPR;TPYIVLSGSGK;TLGEIPTYGLAGNR;QLQQLQQLR) |
2 |
IPI00021417.3, IPI00784194.1
|
1095 |
IPI00021428.1 |
Actin, alpha skeletal muscle |
PM(G1); Cyto(SP,GO) |
2.83E+00 (AGFAGDDAPR;AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;SYELPDGQVITIGNER;DLTDYLMK;DLTDYLMKILTER;VAPEEHPTLLTEAPLNPK;YPIEHGIITNWDDMEK;EITALAPSTMK;QEYDEAGPSIVHR;GYSFVTTAER) |
- |
- |
8.23E-01 (AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;SYELPDGQVITIGNER;DLTDYLMK;VAPEEHPTLLTEAPLNPK;YPIEHGIITNWDDMEK;EITALAPSTMK;QEYDEAGPSIVHR;TTGIVLDSGDGVTHNVPIYEGYALPHAIMR;GYSFVTTAER) |
9.71E-01 (AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;SYELPDGQVITIGNER;DLTDYLMK;VAPEEHPTLLTEAPLNPK;YPIEHGIITNWDDMEK;EITALAPSTMK;DLYANNVMSGGTTMYPGIADR;QEYDEAGPSIVHR;TTGIVLDSGDGVTHNVPIYEGYALPHAIMR) |
3.02E-01 (IWHHTFYNELR;AVFPSIVGR;AVFPSIVGRPR;SYELPDGQVITIGNER;DLTDYLMK;VAPEEHPTLLTEAPLNPK;GYSFVTTAER) |
1 |
IPI00021428.1
|
1096 |
IPI00021435.2 |
26S protease regulatory subunit 7 |
Cyto(SP,GO,HPA); Nucl(SP,GO,HPA); Mito(GO,HPA) |
- |
2.83E-01 (ACLIFFDEIDAIGGAR;ESDTGLAPPALWDLAADK;IATEKDFLEAVNK;QTLQSEQPLQVAR;YQIHIPLPPK;EVVETPLLHPER;KIATEKDFLEAVNK;KIEFSLPDLEGR;TMLELINQLDGFDPR;LREVVETPLLHPER;FVNLGIEPPK;ALDEGDIALLK;VIGSELVQK;GVLLFGPPGT |
- |
- |
- |
8.73E-02 (ACLIFFDEIDAIGGAR;EVVETPLLHPER;FVNLGIEPPK;YQIHIPLPPK;KIEFSLPDLEGR) |
1 |
IPI00021435.2
|
1097 |
IPI00021440.1 |
Actin, cytoplasmic 2 |
PM(G1); Cyto(SP,GO) |
6.06E+01 (AGFAGDDAPR;AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;VAPEEHPVLLTEAPLNPK;VAPEEHPVLLTEAPLNPKANR;QEYDESGPSIVHR;SYELPDGQVITIGNER;DLTDYLMK;DLTDYLMKILTER;TTGIVMDSGDGVTHTVPIYEGYALPHAILR;EITALAPSTMK;DLYANTV |
1.79E+01 (DLYANTVLSGGTTMYPGIADR;EITALAPSTMK;EKLCYVALDFEQEMATAASSSSLEK;IIAPPERKYSVWIGGSILASLSTFQQMWISK;IWHHTFYNELR;LCYVALDFEQEMATAASSSSLEK;TTGIVMDSGDGVTHTVPIYEGYALPHAILR;QEYDESGPSIVHR;AVFPSIVGR;AVFPSIV |
9.92E-01 (QEYDESGPSIVHR;AVFPSIVGR;VAPEEHPVLLTEAPLNPK;SYELPDGQVITIGNER;GYSFTTTAER) |
1.63E+01 (AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;VAPEEHPVLLTEAPLNPK;QEYDESGPSIVHR;SYELPDGQVITIGNER;DLTDYLMK;TTGIVMDSGDGVTHTVPIYEGYALPHAILR;EITALAPSTMK;DLYANTVLSGGTTMYPGIADR;KDLYANTVLSGGTTMYPGIADR;GYSFTTTAE |
1.62E+01 (VAPEEHPVLLTEAPLNPK;AVFPSIVGR;AVFPSIVGRPR;IWHHTFYNELR;QEYDESGPSIVHR;SYELPDGQVITIGNER;DLTDYLMK;TTGIVMDSGDGVTHTVPIYEGYALPHAILR;MTQIMFETFNTPAMYVAIQAVLSLYASGR;EITALAPSTMK;DLYANTVLSGGTTMYPGIADR;GY |
1.50E+01 (DLYANTVLSGGTTMYPGIADR;IWHHTFYNELR;LCYVALDFEQEMATAASSSSLEK;QEYDESGPSIVHR;AVFPSIVGR;AVFPSIVGRPR;GYSFTTTAER;SYELPDGQVITIGNER;TTGIVMDSGDGVTHTVPIYEGYALPHAILR;VAPEEHPVLLTEAPLNPK;DLTDYLMK) |
2 |
IPI00021440.1, IPI00021439.1
|
1098 |
IPI00021458.1 |
EH-domain-containing protein 3 |
PM(SP); Nucl(GO) |
- |
1.98E-02 (LDISDEFSEVIK;VYIGSFWSHPLLIPDNR;FVCAQLPNPVLESISVIDTPGILSGEK;FHEFHSPALEDADFDNKPMVLLVGQYSTGK) |
- |
2.23E-02 (LDISDEFSEVIK;EHQISPGDFPNLK) |
2.14E-01 (DKPMYDEIFYTLSPVDGK;GGAFEGTLHGPFGHGYGEGAGEGIDDAEWVVAR;LADIDKDGMLDDDEFALANHLIK;LDISDEFSEVIK;LFEAEEQDLFR;LNAFGNAFLNR;MQDQLQAQDFSK;VYGALMWSLGK;VYIGSFWSHPLLIPDNR;EHQISPGDFPNLK) |
- |
2 |
IPI00749074.1, IPI00021458.1
|
1099 |
IPI00021537.4 |
Isoform 1 of Opioid growth factor receptor |
Nucl(G2) |
- |
7.20E-02 (SLGELGLEHFQAPLVR;DCNGDTPNLSFYR;TGTQEVGGQDPGEAVQPCR;HNYPDLVER) |
- |
- |
- |
- |
3 |
IPI00021537.4, IPI00216130.7, IPI00641613.2
|
1100 |
IPI00021671.2 |
hypothetical protein LOC23240 |
Cyto(G2) |
1.80E-02 (IHKTSREDMFSEK;SVVLNDVFLSK) |
- |
- |
- |
- |
- |
2 |
IPI00021671.2, IPI00384634.2
|
1101 |
IPI00021695.1 |
Isoform D of Plasma membrane calcium-transporting ATPase 1 |
PM(SP,GO) |
- |
6.04E-03 (CGILHPGEDFLCLEGKDFNR;EASDIILTDDNFTSIVK) |
- |
- |
3.05E-02 (SSLYEGLEKPESR;QVVAVTGDGTNDGPALK;YGDLLPADGILIQGNDLK;MTVVQAYINEK) |
1.45E-02 (IDESSLTGESDHVK;IDESSLTGESDHVKK) |
4 |
IPI00216530.1, IPI00216528.1, IPI00216527.1, IPI00021695.1
|
1102 |
IPI00021700.3 |
Proliferating cell nuclear antigen |
Nucl(SP,GO,HPA); Cyto(GO) |
- |
3.11E-01 (ATPLSSTVTLSMSADVPLVVEYK;CAGNEDIITLR;FSASGELGNGNIK;LSQTSNVDKEEEAVTIEMNEPVQLTFALR;AEDNADTLALVFEAPNQEK;DLSHIGDAVVISCAK) |
- |
- |
- |
1.77E-01 (FSASGELGNGNIK;AEDNADTLALVFEAPNQEK;CAGNEDIITLR) |
1 |
IPI00021700.3
|
1103 |
IPI00021701.7 |
IMP dehydrogenase/GMP reductase family protein |
Cyto(SP) |
- |
6.55E-03 (EVYSILQAEGILLPR;VYTVGPDYAHAEAR) |
- |
- |
- |
- |
3 |
IPI00021701.7, IPI00178375.3, IPI00784254.1
|
1104 |
IPI00021711.1 |
HLA class II histocompatibility antigen, DP alpha chain precursor |
ER(SP); PM(SP,GO) |
- |
- |
- |
- |
9.98E-02 (VEHWGLDKPLLK;VEHWGLDQPLLK;ADHVSTYAAFVQTHR) |
- |
3 |
IPI00798162.1, IPI00644713.2, IPI00021711.1
|
1105 |
IPI00021727.1 |
C4b-binding protein alpha chain precursor |
ER(G1) |
- |
- |
- |
3.73E-01 (EDVYVVGTVLR;KPDVSHGEMVSGFGPIYNYK;LSLEIEQLELQR;MALEVYK;PDVSHGEMVSGFGPIYNYK) |
1.46E-01 (EDVYVVGTVLR;KPDVSHGEMVSGFGPIYNYK;LSLEIEQLELQR) |
4.32E-02 (LSLEIEQLELQR;EDVYVVGTVLR) |
1 |
IPI00021727.1
|
1106 |
IPI00021766.4 |
Isoform 1 of Reticulon-4 |
ER(SP); Nucl(GO); PM(GO) |
- |
- |
8.90E-02 (YSNSALGHVNCTIK;HQAQIDHYLGLANK) |
- |
1.66E-01 (AYLESEVAISEELVQK;HQAQIDHYLGLANK;LFLVDDLVDSLK;RLFLVDDLVDSLK;GSSGSVDETLFALPAASEPVIR) |
1.77E-01 (YSNSALGHVNCTIK;AYLESEVAISEELVQK;HQAQIDHYLGLANK) |
2 |
IPI00478442.2, IPI00021766.4
|
1107 |
IPI00021772.1 |
S-adenosylmethionine synthetase isoform type-1 |
Cyto(G1,GO) |
- |
2.87E+00 (TCNVLVALEQQSPDIAQCVHLDR;ICDQISDAVLDAHLK;TQVTVQYMQDNGAVIPVR;NEEDVGAGDQGLMFGYATDETEECMPLTIILAHK;SGLLPWLRPDSK;IIVDTYGGWGAHGGGAFSGK;YLDEDTVYHLQPSGR;ELLDVVHK;FVIGGPQGDAGVTGR;IHTIVISVQHNEDITLEEMR; |
- |
9.88E-02 (FVIGGPQGDAGVTGR;YLDEDTVYHLQPSGR) |
1.59E-01 (FVIGGPQGDAGVTGR;YLDEDTVYHLQPSGR) |
- |
1 |
IPI00021772.1
|
1108 |
IPI00021785.2 |
Cytochrome c oxidase subunit 5B, mitochondrial precursor |
Mito(SP,GO,MitoP2,HPA) |
2.05E+00 (EDPNLVPSISNK;GLDPYNVLAPK;IVGCICEEDNTSVVWFWLHK;KGLDPYNVLAPK) |
- |
- |
2.24E-01 (EDPNLVPSISNK;KGLDPYNVLAPK;GLDPYNVLAPK) |
2.01E-01 (EDPNLVPSISNK;KGLDPYNVLAPK) |
- |
1 |
IPI00021785.2
|
1109 |
IPI00021793.1 |
Cytochrome c oxidase polypeptide VIa-liver, mitochondrial precursor |
Mito(SP,GO,MitoP2) |
6.72E-01 (SHHGEHERPEFIAYPHLR;TKPFPWGDGNHTLFHNPHVNPLPTGYEDE) |
- |
- |
- |
5.22E-01 (SHHGEHERPEFIAYPHLR;TLTFFVALPGVAVSMLNVYLK) |
- |
2 |
IPI00021793.1, IPI00176681.1
|
1110 |
IPI00021800.1 |
Isoform Alpha of Caspase-1 precursor |
Cyto(SP,GO) |
- |
6.14E-02 (DSVGVSGNLSLPTTEEFEDDAIKK;LALIICNEEFDSIPR;VIIIQACR;HPTMGSVFIGR) |
- |
- |
- |
- |
8 |
IPI00021800.1, IPI00219307.1, IPI00219308.1, IPI00744512.1, IPI00789254.1, IPI00797075.1, IPI00798290.1, IPI00807357.1
|